Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
09:15am, Thursday, 22'nd Aug 2024
Live moderated webcast with John Climaco, Chief Executive Officer of CNS Pharmaceuticals on Monday, August 26th at 12:00 PM ET Participants have the ability to submit questions live during the Q&A por
Corero Network Security Expands Strategic Partnerships in Latin America with New Agreements and Client Wins in Chile
07:00am, Thursday, 22'nd Aug 2024
MARLBOROUGH, Mass. , Aug. 22, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced the signing of th
Cohen & Steers Appoints Lisa Dolly to Board of Directors
08:00am, Monday, 19'th Aug 2024
NEW YORK , Aug. 19, 2024 /PRNewswire/ -- Cohen & Steers, Inc.'s (NYSE: CNS) Board of Directors has appointed Lisa Dolly as a director of the company. Ms. Dolly has also been appointed as a member of t
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
08:00am, Thursday, 15'th Aug 2024
Potentially pivotal GBM study evaluating lead program, Berubicin, enrollment completed; Topline data expected in the first half of 2025 Recent strategic in-license of TPI 287 is highly synergistic wit
Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration
02:00pm, Wednesday, 14'th Aug 2024
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
07:30am, Tuesday, 13'th Aug 2024
Plus' CNSide leptomeningeal metastases (LM) FORSEE trial met key primary and secondary endpoints CNSide more than doubled the diagnostic sensitivity vs. gold standard cerebral spinal fluid (CSF) cytol
Respect-LM dosing shows continued feasibility and safety of up to 44 mCi of intrathecal Rhenium ( 186 Re) Obisbemeda High absorbed radiation doses, mean circulating tumor cell reductions, and median o
Cohen & Steers Announces Changes to Realty Indexes
04:05pm, Friday, 09'th Aug 2024
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Ind
Cohen & Steers (CNS) July AUM Jumps 4.8% on Upbeat Markets
09:15am, Friday, 09'th Aug 2024
Cohen & Steers (CNS) witnesses a 4.8% rise in July AUM balance, driven by solid market appreciation.
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For July 2024
04:38pm, Thursday, 08'th Aug 2024
NEW YORK , Aug. 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $84.6 billion as of July 31, 2024, an increase of $3.9 billion from asse
Cohen & Steers, Inc. Declares Quarterly Dividend
04:15pm, Thursday, 01'st Aug 2024
NEW YORK , Aug. 1, 2024 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the third quarter of 2024 in the amount of $0.59 per share of common sto
Strategic in-license from Cortice Bioscience is highly synergistic with the ongoing potentially pivotal Berubicin program and demonstrates further commitment to changing the treatment paradigm in GBM
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
09:05am, Thursday, 25'th Jul 2024
HOUSTON, TX / ACCESSWIRE / July 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
07:02pm, Wednesday, 24'th Jul 2024
NEW YORK , July 24, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
06:59pm, Wednesday, 24'th Jul 2024
NEW YORK , July 24, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
